Zolpidem antioxidant and neuroprotective effects on acrylamide-induced neurotoxicity using primary neuronal cortical culture
محل انتشار: پانزدهمین همایش سراسری سم شناسی ایران
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 383
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
TOXICOLOGY15_060
تاریخ نمایه سازی: 15 بهمن 1398
چکیده مقاله:
Zolpidem is an introduced medication for treatment of sleeping disorders. The pharmacological effect of zolpidem is consequently characterized by a quick onset and a half-life of 2.4 h. Previous studies revealed the antioxidant and neuro-protectant effects of zolpidem. In this research, the aim was to demonstrate the exact sub-cellular/molecular mechanism of this medication using the primary neuronal cortical culture.MethodsFirst the cortical neurons were isolated from the postnatal Wistar rat pups. Thereafter, different neural toxicity endpoints -created by acrylamide- including reactive oxygen species (ROS) formation, lipid peroxidation, mitochondrial membrane potential collapse, lysosomal membrane integrity and apoptosis were measured. All of these parameters are upstream events of cellular apoptosis which justifies neurodegeneration involved in many diseases such as Alzheimer, Parkinson and etc.ResultsAttained results demonstrated that zolpidem at concentrations of 1 and 2mM prevented all the mentioned acrylamide-induced neural upstream toxic events leading to neuronal apoptosis.ConclusionThese results revealed that zolpidem has antioxidant and neuro-protective properties that make it a promising prophylactic agent to prevent neuro-degenerative complications. Considering the important role of oxidative stress in the development or progression of diseases, if the used medication for the treatment of a disease has antioxidant properties, it will certainly help to achieve a better healing.
کلیدواژه ها:
نویسندگان
Nasim Akbarizadeh
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid BeheshtiUniversity of Medical Sciences, Tehran, IR Iran
Parvaneh Naserzadeh
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid BeheshtiUniversity of Medical Sciences, Tehran, IR Iran
Jalal Pourahmad
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid BeheshtiUniversity of Medical Sciences, Tehran, IR Iran
Bahare Sadat Yousefsani
Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran